DBMR - Pharmaceutical

Global Drug Screening Market – Industry Trends - Forecast to 2026

  • Pharmaceutical
  • Upcoming Report
  • May 2019
  • Global
  • 150 Pages
  • No of Tables: 50
  • No of Figures: 250

Global Drug Screening Market By Products and Services [Equipment (Immunoassay Analyzers, Chromatography Instruments, and Breath Analyzers {Semiconductor Breath Analyzers and Fuel Cell Analyzers}, Rapid Testing Devices(RTD) {Oral Fluid Testing Devices and Urine Testing Devices}), Consumables {Assay Kits, Calibrators & Controls, and Sample Collection Cups} and Laboratory Services], Sample Type (Urine, Breath, Saliva, Hair, Blood, Skin, Sweat), End User (Workplace & Schools, Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, and Pain Management Centers),  Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Drug Screening Market

Global Drug Screening Market is expected to rise gradually to an estimated value of USD 19.03 billion by 2026, registering a CAGR of 12.9% in the forecast period of 2019-2026 with the annual sales of USD 7.21 billion in the year 2018. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of people.

Market Definition: Global Drug Screening Market

Drug screening is used for detecting prescribed as well as illegal drugs in blood, urine, and other biological samples basically at hospitals, places of employment, trained athletes, schools and post-accident. It is considered as a basic part of ongoing diagnosis and treatment, can be by purpose or random. Drug screening takes place at the time of some suspicious cause, generally before employment or sports event. Few of the illegal drugs are cocaine, heroin, amphetamine and cannabis along with which new psychoactive substances (NPS), for instance, ketamine, phenethylamines, and piperazine are rising in the drug market.

According to World Health Organization, there were an estimated 3.3 million people died due to harmful effects of only alcohol, almost more than half of these deaths could have been avoided with the development, organization, monitoring and evaluation of treatment and other services. This significant number is expected to act as a driver to the market growth.

Market Drivers

  • Increasing government funding and initiatives for drug testing.

  • Rising awareness on drug screening policy

  • Growing alcohol and drug abuse in developing countries.

Market Restraints

  • In some countries drug testing is considered as a violation of privacy rights.
  • Accuracy issues with the breathalyzers.

Segmentation: Global Drug Screening Market

By Product and services

  • Equipment

    • Immunoassay Analyzers
    • Chromatography Instruments
    • Breath Analyzers

      • Fuel Cell Breathalyzers
      • Semiconductor Breathalyzers
      • Other Devices

  • Rapid Testing Devices

    • Urine Testing Devices

      • Urine Testing Cups
      • Dip Cards
      • Cassettes

    • Oral Fluid Testing Devices

  • Consumables

    • Assay Kits
    • Sample Collection Cups
    • Calibrators and Controls
    • Others

  • Laboratory Services

By Sample Type

  • Urine
  • Breath
  • Saliva, Hair
  • Blood
  • Skin
  • Sweat

By End- users

  • Workplace and Schools
  • Drug Testing Laboratories
  • Criminal Justice System & Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Pain Management Centers
  • Personal Users

By Geography

  • North America

    • US.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Argentina
    • Rest of South America

  • Europe

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific

  • Middle East & Africa

    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East & Africa

Key Developments in the Market:

  • On 6th July, 2017, Endo Pharmaceuticals agreed to remove Opana ER (oxymorphone), its abuse-deterrent extended-release formulation of from the US market a month later the US Food and Drug Administration (FDA) asked the company to stop selling the pain medication.

  • On 19th July 2017, Alere Inc., a global leader in rapid diagnostics, announced the availability of Alere iCup , its point-of-care Rx Drug Screen, a rapid urine test that detects five of the most commonly misused and abused prescription drugs which are benzodiazepines, buprenorphine, methadone, opiates and oxycodone. This innovative approach will help the company to generate more revenue.

Competitive Analysis:

Global drug screening market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of drug screening market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the drug screening market are Siemens Healthcare GmbH (Germany), Quest Diagnostics Incorporated (U.S.), Alere (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Abbott (U.S.),Hoffmann -La Roche Ltd(Switzerland), BioMerieux SA (France),  Express Diagnostics Int’l, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories Inc. (U.S), Biomedical Diagnostics (Belgium),  CannAmm (Cannada), MPD, Inc. (U.S.), Danaher (U.S.), Synergy Health plc.(U.K), Agilent Technologies (U.S), Shimadzu Medical Pvt. Ltd. (Japan) and few among others.

Research Methodology: Global Drug Screening Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global drug screening market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART